A new study led by NYU Langone Health researchers found that cancer cells are better able to resist treatments when they have ...
JA Rosenfeld is an employee of Signature Genomic Laboratories, a subsidiary of PerkinElmer, Inc. The authors have no other relevant affiliations or financial involvement with any organization or ...
Carfilzomib or bortezomib with lenalidomide, and dexamethasone (VRd) for initial therapy of newly diagnosed multiple myeloma (NDMM): Long-term follow-up of the ECOG-ACRIN ENDURANCE phase 3 trial. Real ...
The vast dataset allowed the Johns Hopkins University-led team to demonstrate robust connections between specific variations in a mother's DNA and their risk of miscarriage. The findings shed new ...
Individuals that share the same deletion of a portion of chromosome 16 are at risk of developing neurodevelopmental disorders ...
Sex chromosome abnormalities, including missing or extra X and Y chromosomes, can be difficult to detect in ancient DNA as it slowly erodes over time or becomes contaminated. Scientists have now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results